Publications by authors named "Jose Cepeda"

Claim this Profile
E
Effectiveness and safety of rivaroxaban in patients with atrial fibrillation and heart failure in clinical practice: an indirect comparison of national and international registries.
Jose Maria Cepeda, Nicolas Manito, Alejandro Recio Mayoral, Iñaki Lekuona, Miguel Castillo Orive

Front Cardiovasc Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study.
Leopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, Ovidio Muñiz-Grijalvo, Rodrigo Alonso, José María Cepeda

Lancet Diabetes Endocrinol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the care of patients with cardiovascular disease in health emergency situations: a call to action.
Carmen Suárez Fernández, Pedro Armario, José María Cepeda, Maria Dolores López Carmona, José Pablo Miramontes González

Curr Med Res Opin· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.
Leopoldo Pérez de Isla, Jose L Díaz-Díaz, Manuel J Romero, Ovidio Muñiz-Grijalvo, Juan D Mediavilla, José María Cepeda

Circulation· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice.
Manuel Montero-Pérez-Barquero, Carlos Escobar-Cervantes, José Carlos Arévalo-Lorido, Alicia Conde-Martel, Prado Salamanca-Bautista, José María Cepeda

Future Cardiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study.
Rodrigo Alonso, Raquel Arroyo-Olivares, Ovidio Muñiz-Grijalvo, Jose Luis Díaz-Díaz, Juan Sanchez Muñoz-Torrero, José Cepeda

Eur J Prev Cardiol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat.
José Ramón González-Juanatey, Josep Comín-Colet, Domingo Pascual Figal, Antoni Bayes-Genis, Jose Maria Cepeda

Patient Prefer Adherence· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience.
Rodrigo Alonso, Ovidio Muñiz-Grijalvo, Jose Luis Díaz-Díaz, Daniel Zambón, Raimundo de Andrés, Jose Cepeda

J Clin Lipidol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation.
Jose María Mostaza, Carmen Suarez, Jose María Cepeda, Luis Manzano, Demetrio Sánchez

BMC Cardiovasc Disord· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of heart failure with preserved ejection fraction: Results from the RICA Registry.
Joan Carles Trullàs, Juan Ignacio Pérez-Calvo, Alicia Conde-Martel, Pau Llàcer Iborra, Iván Suárez Pedreira, José María Cepeda

Med Clin (Barc)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities and their implications in patients with and without type 2 diabetes mellitus and heart failure with preserved ejection fraction. Findings from the rica registry.
José Carlos Arévalo-Lorido, Juana Carretero-Gómez, Ricardo Gómez-Huelgas, Pau Llácer, Luis Manzano, José María Cepeda

Int J Clin Pract· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact of ferric carboxymaltose treatment in patients with chronic heart failure and iron deficiency in Spain.
Juan F Delgado, Juan Oliva, Álvaro González-Franco, Jose María Cepeda, Jose Ángel García-García

J Med Econ· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry.
Leopoldo Pérez de Isla, Raquel Arroyo-Olivares, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, José M Cepeda

Rev Esp Cardiol (Engl Ed)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study.
Leopoldo Pérez de Isla, Raquel Arroyo-Olivares, Ovidio Muñiz-Grijalvo, José Luis Diaz-Díaz, Daniel Zambón, José M Cepeda

J Clin Lipidol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Influence of frailty on anticoagulant prescription and clinical outcomes after 1‑year follow‑up in hospitalised older patients with atrial fibrillation.
Alejandra Gullón, Francesc Formiga, Jesús Díez-Manglano, José María Mostaza, José María Cepeda

Intern Emerg Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation.
Alejandra Gullón, Francesc Formiga, Jesús Díez-Manglano, José María Mostaza, José María Cepeda

Intern Emerg Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban: searching the integral vascular protection.
Vivencio Barrios, Manuel Almendro-Delia, Lorenzo Facila, Xavier Garcia-Moll, Pilar Mazón, José María Cepeda

Expert Rev Clin Pharmacol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of atrial fibrillation on the mortality of patients with heart failure with preserved ejection fraction.
Jonathan Franco, Francesc Formiga, Jose Cepeda, Pau Llacer, Juan Arévalo-Lorido

Med Clin (Barc)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia.
Rafael Escate, Pedro Mata, Jose Maria Cepeda, Teresa Padreó, Lina Badimon

FASEB J· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia.
Rafael Escate, Pedro Mata, Jose Maria Cepeda, Teresa Padró, Lina Badimon

FASEB J· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, Cristina Fernández-Pérez, Ovidio Muñiz, José María Cepeda

Circulation· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
Alejandra Gullón, Carmen Suárez, Jesús Díez-Manglano, Francesc Formiga, José María Cepeda

Med Clin (Barc)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation.
Carme Pinyol, Jose Mª Cepeda, Inmaculada Roldan, Vanesa Roldan, Silvia Jimenez

Cardiol Ther· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.
Francisco Fuentes, Juan F Alcala-Diaz, Gerald F Watts, Rodrigo Alonso, Ovidio Muñiz, Jose M Cepeda

Int J Cardiol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Possibilities of clinical echocardiography in patients with heart failure: some examples from clinical practice].
Pedro Conthe, José M Cepeda

Med Clin (Barc)· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis